Global IVD Antibodies Market Growth (Status and Outlook) 2025-2031

September 2025 | 84 pages | ID: GBA3A09A8978EN
LP Information

Abstracts

According to this study, the global IVD Antibodies market size will reach US$ million by 2031.

In vitro diagnostics tests are used in laboratories, healthcare settings or directly by consumers at home for the detection of various diseases, infections and other medical conditions. Various companies in the IVD antibodies market are focusing on mergers and acquisitions with regional players. For example, in Sep. 2018, Summa Equity AB acquired Turku-based HyTest Ltd. whose regional presence in the U.S. and Asia is good. Continuously evolving nature of IVD antibodies market further expected to get maximum traction. Superior capability of the IVD antibodies to detect complex diseases such as cancer and use of IVD antibodies in therapeutic monitoring, evaluating blood safety before transfusion further makes it preferred choice of diagnosis test.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “IVD Antibodies Industry Forecast” looks at past sales and reviews total world IVD Antibodies sales in 2024, providing a comprehensive analysis by region and market sector of projected IVD Antibodies sales for 2025 through 2031. With IVD Antibodies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IVD Antibodies industry.

This Insight Report provides a comprehensive analysis of the global IVD Antibodies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on IVD Antibodies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global IVD Antibodies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IVD Antibodies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IVD Antibodies.

This report presents a comprehensive overview, market shares, and growth opportunities of IVD Antibodies market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Cardiac Markers
• Tumor Markers
• Kidney Injury Markers

Segmentation by Application:

• Hospital
• Specialty Clinic
• Diagnostic Center
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abcam
• Thermo Fisher Scientific
• Rockland Immunochemicals
• GenScript
• Bio-Rad Laboratories
• SDIX
• MEDICAL & BIOLOGICAL LABORATORIES
• HyTest
• Abbott

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global IVD Antibodies Market Size (2020-2031)
  2.1.2 IVD Antibodies Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for IVD Antibodies by Country/Region (2020, 2024 & 2031)
2.2 IVD Antibodies Segment by Type
  2.2.1 Cardiac Markers
  2.2.2 Tumor Markers
  2.2.3 Kidney Injury Markers
2.3 IVD Antibodies Market Size by Type
  2.3.1 IVD Antibodies Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global IVD Antibodies Market Size Market Share by Type (2020-2025)
2.4 IVD Antibodies Segment by Application
  2.4.1 Hospital
  2.4.2 Specialty Clinic
  2.4.3 Diagnostic Center
  2.4.4 Others
2.5 IVD Antibodies Market Size by Application
  2.5.1 IVD Antibodies Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global IVD Antibodies Market Size Market Share by Application (2020-2025)

3 IVD ANTIBODIES MARKET SIZE BY PLAYER

3.1 IVD Antibodies Market Size Market Share by Player
  3.1.1 Global IVD Antibodies Revenue by Player (2020-2025)
  3.1.2 Global IVD Antibodies Revenue Market Share by Player (2020-2025)
3.2 Global IVD Antibodies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 IVD ANTIBODIES BY REGION

4.1 IVD Antibodies Market Size by Region (2020-2025)
4.2 Global IVD Antibodies Annual Revenue by Country/Region (2020-2025)
4.3 Americas IVD Antibodies Market Size Growth (2020-2025)
4.4 APAC IVD Antibodies Market Size Growth (2020-2025)
4.5 Europe IVD Antibodies Market Size Growth (2020-2025)
4.6 Middle East & Africa IVD Antibodies Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas IVD Antibodies Market Size by Country (2020-2025)
5.2 Americas IVD Antibodies Market Size by Type (2020-2025)
5.3 Americas IVD Antibodies Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC IVD Antibodies Market Size by Region (2020-2025)
6.2 APAC IVD Antibodies Market Size by Type (2020-2025)
6.3 APAC IVD Antibodies Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe IVD Antibodies Market Size by Country (2020-2025)
7.2 Europe IVD Antibodies Market Size by Type (2020-2025)
7.3 Europe IVD Antibodies Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa IVD Antibodies by Region (2020-2025)
8.2 Middle East & Africa IVD Antibodies Market Size by Type (2020-2025)
8.3 Middle East & Africa IVD Antibodies Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL IVD ANTIBODIES MARKET FORECAST

10.1 Global IVD Antibodies Forecast by Region (2026-2031)
  10.1.1 Global IVD Antibodies Forecast by Region (2026-2031)
  10.1.2 Americas IVD Antibodies Forecast
  10.1.3 APAC IVD Antibodies Forecast
  10.1.4 Europe IVD Antibodies Forecast
  10.1.5 Middle East & Africa IVD Antibodies Forecast
10.2 Americas IVD Antibodies Forecast by Country (2026-2031)
  10.2.1 United States Market IVD Antibodies Forecast
  10.2.2 Canada Market IVD Antibodies Forecast
  10.2.3 Mexico Market IVD Antibodies Forecast
  10.2.4 Brazil Market IVD Antibodies Forecast
10.3 APAC IVD Antibodies Forecast by Region (2026-2031)
  10.3.1 China IVD Antibodies Market Forecast
  10.3.2 Japan Market IVD Antibodies Forecast
  10.3.3 Korea Market IVD Antibodies Forecast
  10.3.4 Southeast Asia Market IVD Antibodies Forecast
  10.3.5 India Market IVD Antibodies Forecast
  10.3.6 Australia Market IVD Antibodies Forecast
10.4 Europe IVD Antibodies Forecast by Country (2026-2031)
  10.4.1 Germany Market IVD Antibodies Forecast
  10.4.2 France Market IVD Antibodies Forecast
  10.4.3 UK Market IVD Antibodies Forecast
  10.4.4 Italy Market IVD Antibodies Forecast
  10.4.5 Russia Market IVD Antibodies Forecast
10.5 Middle East & Africa IVD Antibodies Forecast by Region (2026-2031)
  10.5.1 Egypt Market IVD Antibodies Forecast
  10.5.2 South Africa Market IVD Antibodies Forecast
  10.5.3 Israel Market IVD Antibodies Forecast
  10.5.4 Turkey Market IVD Antibodies Forecast
10.6 Global IVD Antibodies Forecast by Type (2026-2031)
10.7 Global IVD Antibodies Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market IVD Antibodies Forecast

11 KEY PLAYERS ANALYSIS

11.1 Abcam
  11.1.1 Abcam Company Information
  11.1.2 Abcam IVD Antibodies Product Offered
  11.1.3 Abcam IVD Antibodies Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Abcam Main Business Overview
  11.1.5 Abcam Latest Developments
11.2 Thermo Fisher Scientific
  11.2.1 Thermo Fisher Scientific Company Information
  11.2.2 Thermo Fisher Scientific IVD Antibodies Product Offered
  11.2.3 Thermo Fisher Scientific IVD Antibodies Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Thermo Fisher Scientific Main Business Overview
  11.2.5 Thermo Fisher Scientific Latest Developments
11.3 Rockland Immunochemicals
  11.3.1 Rockland Immunochemicals Company Information
  11.3.2 Rockland Immunochemicals IVD Antibodies Product Offered
  11.3.3 Rockland Immunochemicals IVD Antibodies Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Rockland Immunochemicals Main Business Overview
  11.3.5 Rockland Immunochemicals Latest Developments
11.4 GenScript
  11.4.1 GenScript Company Information
  11.4.2 GenScript IVD Antibodies Product Offered
  11.4.3 GenScript IVD Antibodies Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 GenScript Main Business Overview
  11.4.5 GenScript Latest Developments
11.5 Bio-Rad Laboratories
  11.5.1 Bio-Rad Laboratories Company Information
  11.5.2 Bio-Rad Laboratories IVD Antibodies Product Offered
  11.5.3 Bio-Rad Laboratories IVD Antibodies Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Bio-Rad Laboratories Main Business Overview
  11.5.5 Bio-Rad Laboratories Latest Developments
11.6 SDIX
  11.6.1 SDIX Company Information
  11.6.2 SDIX IVD Antibodies Product Offered
  11.6.3 SDIX IVD Antibodies Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 SDIX Main Business Overview
  11.6.5 SDIX Latest Developments
11.7 MEDICAL & BIOLOGICAL LABORATORIES
  11.7.1 MEDICAL & BIOLOGICAL LABORATORIES Company Information
  11.7.2 MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Product Offered
  11.7.3 MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 MEDICAL & BIOLOGICAL LABORATORIES Main Business Overview
  11.7.5 MEDICAL & BIOLOGICAL LABORATORIES Latest Developments
11.8 HyTest
  11.8.1 HyTest Company Information
  11.8.2 HyTest IVD Antibodies Product Offered
  11.8.3 HyTest IVD Antibodies Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 HyTest Main Business Overview
  11.8.5 HyTest Latest Developments
11.9 Abbott
  11.9.1 Abbott Company Information
  11.9.2 Abbott IVD Antibodies Product Offered
  11.9.3 Abbott IVD Antibodies Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Abbott Main Business Overview
  11.9.5 Abbott Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. IVD Antibodies Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. IVD Antibodies Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Cardiac Markers
Table 4. Major Players of Tumor Markers
Table 5. Major Players of Kidney Injury Markers
Table 6. IVD Antibodies Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global IVD Antibodies Market Size by Type (2020-2025) & ($ millions)
Table 8. Global IVD Antibodies Market Size Market Share by Type (2020-2025)
Table 9. IVD Antibodies Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global IVD Antibodies Market Size by Application (2020-2025) & ($ millions)
Table 11. Global IVD Antibodies Market Size Market Share by Application (2020-2025)
Table 12. Global IVD Antibodies Revenue by Player (2020-2025) & ($ millions)
Table 13. Global IVD Antibodies Revenue Market Share by Player (2020-2025)
Table 14. IVD Antibodies Key Players Head office and Products Offered
Table 15. IVD Antibodies Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global IVD Antibodies Market Size by Region (2020-2025) & ($ millions)
Table 19. Global IVD Antibodies Market Size Market Share by Region (2020-2025)
Table 20. Global IVD Antibodies Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global IVD Antibodies Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas IVD Antibodies Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas IVD Antibodies Market Size Market Share by Country (2020-2025)
Table 24. Americas IVD Antibodies Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas IVD Antibodies Market Size Market Share by Type (2020-2025)
Table 26. Americas IVD Antibodies Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas IVD Antibodies Market Size Market Share by Application (2020-2025)
Table 28. APAC IVD Antibodies Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC IVD Antibodies Market Size Market Share by Region (2020-2025)
Table 30. APAC IVD Antibodies Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC IVD Antibodies Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe IVD Antibodies Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe IVD Antibodies Market Size Market Share by Country (2020-2025)
Table 34. Europe IVD Antibodies Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe IVD Antibodies Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa IVD Antibodies Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa IVD Antibodies Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa IVD Antibodies Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of IVD Antibodies
Table 40. Key Market Challenges & Risks of IVD Antibodies
Table 41. Key Industry Trends of IVD Antibodies
Table 42. Global IVD Antibodies Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global IVD Antibodies Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global IVD Antibodies Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global IVD Antibodies Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Abcam Details, Company Type, IVD Antibodies Area Served and Its Competitors
Table 47. Abcam IVD Antibodies Product Offered
Table 48. Abcam IVD Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Abcam Main Business
Table 50. Abcam Latest Developments
Table 51. Thermo Fisher Scientific Details, Company Type, IVD Antibodies Area Served and Its Competitors
Table 52. Thermo Fisher Scientific IVD Antibodies Product Offered
Table 53. Thermo Fisher Scientific IVD Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Thermo Fisher Scientific Main Business
Table 55. Thermo Fisher Scientific Latest Developments
Table 56. Rockland Immunochemicals Details, Company Type, IVD Antibodies Area Served and Its Competitors
Table 57. Rockland Immunochemicals IVD Antibodies Product Offered
Table 58. Rockland Immunochemicals IVD Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Rockland Immunochemicals Main Business
Table 60. Rockland Immunochemicals Latest Developments
Table 61. GenScript Details, Company Type, IVD Antibodies Area Served and Its Competitors
Table 62. GenScript IVD Antibodies Product Offered
Table 63. GenScript IVD Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. GenScript Main Business
Table 65. GenScript Latest Developments
Table 66. Bio-Rad Laboratories Details, Company Type, IVD Antibodies Area Served and Its Competitors
Table 67. Bio-Rad Laboratories IVD Antibodies Product Offered
Table 68. Bio-Rad Laboratories IVD Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Bio-Rad Laboratories Main Business
Table 70. Bio-Rad Laboratories Latest Developments
Table 71. SDIX Details, Company Type, IVD Antibodies Area Served and Its Competitors
Table 72. SDIX IVD Antibodies Product Offered
Table 73. SDIX IVD Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. SDIX Main Business
Table 75. SDIX Latest Developments
Table 76. MEDICAL & BIOLOGICAL LABORATORIES Details, Company Type, IVD Antibodies Area Served and Its Competitors
Table 77. MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Product Offered
Table 78. MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. MEDICAL & BIOLOGICAL LABORATORIES Main Business
Table 80. MEDICAL & BIOLOGICAL LABORATORIES Latest Developments
Table 81. HyTest Details, Company Type, IVD Antibodies Area Served and Its Competitors
Table 82. HyTest IVD Antibodies Product Offered
Table 83. HyTest IVD Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. HyTest Main Business
Table 85. HyTest Latest Developments
Table 86. Abbott Details, Company Type, IVD Antibodies Area Served and Its Competitors
Table 87. Abbott IVD Antibodies Product Offered
Table 88. Abbott IVD Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Abbott Main Business
Table 90. Abbott Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. IVD Antibodies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global IVD Antibodies Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. IVD Antibodies Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. IVD Antibodies Sales Market Share by Country/Region (2024)
Figure 8. IVD Antibodies Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global IVD Antibodies Market Size Market Share by Type in 2024
Figure 10. IVD Antibodies in Hospital
Figure 11. Global IVD Antibodies Market: Hospital (2020-2025) & ($ millions)
Figure 12. IVD Antibodies in Specialty Clinic
Figure 13. Global IVD Antibodies Market: Specialty Clinic (2020-2025) & ($ millions)
Figure 14. IVD Antibodies in Diagnostic Center
Figure 15. Global IVD Antibodies Market: Diagnostic Center (2020-2025) & ($ millions)
Figure 16. IVD Antibodies in Others
Figure 17. Global IVD Antibodies Market: Others (2020-2025) & ($ millions)
Figure 18. Global IVD Antibodies Market Size Market Share by Application in 2024
Figure 19. Global IVD Antibodies Revenue Market Share by Player in 2024
Figure 20. Global IVD Antibodies Market Size Market Share by Region (2020-2025)
Figure 21. Americas IVD Antibodies Market Size 2020-2025 ($ millions)
Figure 22. APAC IVD Antibodies Market Size 2020-2025 ($ millions)
Figure 23. Europe IVD Antibodies Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa IVD Antibodies Market Size 2020-2025 ($ millions)
Figure 25. Americas IVD Antibodies Value Market Share by Country in 2024
Figure 26. United States IVD Antibodies Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada IVD Antibodies Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico IVD Antibodies Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil IVD Antibodies Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC IVD Antibodies Market Size Market Share by Region in 2024
Figure 31. APAC IVD Antibodies Market Size Market Share by Type (2020-2025)
Figure 32. APAC IVD Antibodies Market Size Market Share by Application (2020-2025)
Figure 33. China IVD Antibodies Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan IVD Antibodies Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea IVD Antibodies Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia IVD Antibodies Market Size Growth 2020-2025 ($ millions)
Figure 37. India IVD Antibodies Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia IVD Antibodies Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe IVD Antibodies Market Size Market Share by Country in 2024
Figure 40. Europe IVD Antibodies Market Size Market Share by Type (2020-2025)
Figure 41. Europe IVD Antibodies Market Size Market Share by Application (2020-2025)
Figure 42. Germany IVD Antibodies Market Size Growth 2020-2025 ($ millions)
Figure 43. France IVD Antibodies Market Size Growth 2020-2025 ($ millions)
Figure 44. UK IVD Antibodies Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy IVD Antibodies Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia IVD Antibodies Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa IVD Antibodies Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa IVD Antibodies Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa IVD Antibodies Market Size Market Share by Application (2020-2025)
Figure 50. Egypt IVD Antibodies Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa IVD Antibodies Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel IVD Antibodies Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey IVD Antibodies Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries IVD Antibodies Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 56. APAC IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 57. Europe IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 59. United States IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 60. Canada IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 61. Mexico IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 62. Brazil IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 63. China IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 64. Japan IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 65. Korea IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 67. India IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 68. Australia IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 69. Germany IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 70. France IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 71. UK IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 72. Italy IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 73. Russia IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 74. Egypt IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 75. South Africa IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 76. Israel IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 77. Turkey IVD Antibodies Market Size 2026-2031 ($ millions)
Figure 78. Global IVD Antibodies Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global IVD Antibodies Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries IVD Antibodies Market Size 2026-2031 ($ millions)